Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Hidonix to Showcase Next-Gen ION Spatial Intelligence Platform at CES 2026

December 22, 2025

LiTime Unveils Off-Grid Power Solutions for Container Homes, Redefining Energy Freedom in Modern Living

December 22, 2025

Tariff exemptions were Canada’s salvation in 2025. Why they’re at risk in 2026

December 22, 2025

Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program

December 22, 2025

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways

December 22, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030
Press Release

Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030

By News RoomDecember 8, 20233 Mins Read
Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030
Share
Facebook Twitter LinkedIn Pinterest Email
Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030

Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) — The “Pharmaceutical Grade Lactose Market Size, Share & Trends Analysis Report By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose), By Region, And Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical grade lactose market size is expected to reach USD 2.81 billion by 2030, as per the new report by the publisher. The market is expected to expand at a CAGR of 5.4% from 2023 to 2030. This is attributable to the growing demand for novel medicines across the globe. Novel medicines, also known as new or innovative medicines, refer to pharmaceutical products that are newly developed and differ significantly from existing medications. These medicines often involve breakthrough discoveries or advancements in medical science and technology. Novel medicines may include biologics, new chemical entities (NCE), targeted therapies, gene therapies, and immunotherapies. The development of such novel medicines and drugs is driven by a high level of R&D activities being carried out by various drug manufacturing companies around the world.

Additionally, pharmaceutical formulations often require various excipients and manufacturers have a range of options to choose from alternative excipients that offer similar functionality and cost advantages may compete with the product, reducing its market demand. For example, according to JRS PHARMA, EMDEX shows great potential as a viable alternative to spray-dried lactose, as it exhibits comparable characteristics in terms of powder and tableting properties.

The pharmaceutical-grade lactose industry is characterized by intense competition, with multiple companies vying for market share and supplying the product to a wide range of end-users globally. To achieve a competitive edge, it is essential to focus on product launches, expansion, and research and development initiatives. As a result, leading manufacturers operational in the market strive to obtain high level of dominance by undertaking numerous initiatives.

Pharmaceutical Grade Lactose Market Report Highlights

  • The spray dried lactose segment emerged as the fastest growing application segment with a CAGR of 6.0% from 2023 to 2030, due to its ability to enhance the solubility and bioavailability of various pharmaceutical compounds
  • North America emerged as the fastest growing region with a CAGR of 5.8% from 2023 to 2030, the advancing end-use industry, coupled with research & development activities in key countries such as the U.S. and Canada, is anticipated to drive the demand for the product in the region over the forecast period
  • MEGGLE GmbH & Co. KG expanded its distribution network through agreements with exclusive distributors. For instance, it partnered with Barentz for the distribution of its pharmaceutical grade lactose in the U.S. These strategic initiatives are anticipated to collectively enable the company to continue playing a major role in the market
  • Kerry Ingredients India Private Limited and Lactose (India) Limited mutually agreed to terminate their contract for lactose co-manufacturing professionally and amicably. This decision was made in alignment with the strategic goals of both companies to focus on their respective core competencies while continuing to foster a positive and collaborative relationship for future opportunities

Key Attributes:

Report Attribute Details
No. of Pages 142
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $1.84 Billion
Forecasted Market Value (USD) by 2030 $2.81 Billion
Compound Annual Growth Rate 5.4%
Regions Covered Global

Companies Mentioned

  • ARMOR PROTEINES
  • BASF Corporation
  • Charotar Casein Company
  • DFE Pharma
  • Fengchen Group Co., Ltd
  • Kaserei Champignon Hofmeister GmbH & Co. KG
  • Kavya Pharma
  • Kerry
  • Lactalis Ingredients
  • Lactose (India) Limited
  • MEGGLE GmbH & Co. KG
  • Royal FrieslandCampina
  • Surfachem Group Ltd

For more information about this report visit https://www.researchandmarkets.com/r/st18iq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Pharmaceutical Grade Lactose Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Hidonix to Showcase Next-Gen ION Spatial Intelligence Platform at CES 2026

LiTime Unveils Off-Grid Power Solutions for Container Homes, Redefining Energy Freedom in Modern Living

Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways

Meridianbet (GMGI) Secures Belgian Online Casino License

Bitcoin Munari Locks Final Presale Price at $0.015 And Launch Price At $6

DemandScience Earns Top Rankings in G2 Winter 2026 Reports

Peer to Peer Network, Inc. Announces Contract With Hopscotch Air® to Deploy Tier-1 AI Communications Suite

New Crypto Mutuum Finance (MUTM) Reports 250% Token Growth as Phase 6 Nears 100% with Over $19M Raised

Editors Picks

LiTime Unveils Off-Grid Power Solutions for Container Homes, Redefining Energy Freedom in Modern Living

December 22, 2025

Tariff exemptions were Canada’s salvation in 2025. Why they’re at risk in 2026

December 22, 2025

Foremost Clean Energy Announces $9.0 Million 2026 Exploration Program

December 22, 2025

DALI Alliance Launches Test and Certification Specifications for Wireless to DALI Gateways

December 22, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Meridianbet (GMGI) Secures Belgian Online Casino License

December 22, 2025

Bitcoin Munari Locks Final Presale Price at $0.015 And Launch Price At $6

December 22, 2025

DemandScience Earns Top Rankings in G2 Winter 2026 Reports

December 22, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version